• LAST PRICE
    2.6500
  • TODAY'S CHANGE (%)
    Trending Up0.1500 (6.0000%)
  • Bid / Lots
    2.1000/ 1
  • Ask / Lots
    3.8000/ 2
  • Open / Previous Close
    2.6000 / 2.5000
  • Day Range
    Low 2.5900
    High 2.9100
  • 52 Week Range
    Low 1.7700
    High 7.8850
  • Volume
    23,881
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.5
TimeVolumeANEB
09:32 ET1352.6
11:27 ET16932.5998
11:30 ET15002.725
11:34 ET35942.888
11:36 ET18022.9
11:38 ET5002.8914
11:39 ET4002.82
11:43 ET2002.8398
11:48 ET35002.8201
11:50 ET10802.7501
11:54 ET1002.8579
12:19 ET44002.75
12:50 ET3382.7548
01:15 ET9952.7
03:39 ET17002.75
03:46 ET5652.65
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesANEB
Anebulo Pharmaceuticals Inc
67.9M
-7.9x
---
United StatesPRDS
Pardes Biosciences Inc
67.9M
-0.7x
---
United StatesLIFE
aTyr Pharma Inc
67.0M
-1.4x
---
United StatesAXLA
Axcella Health Inc
67.0M
-0.5x
---
United StatesXLO
Xilio Therapeutics Inc
66.8M
-0.8x
---
United StatesPASG
Passage Bio Inc
66.6M
-0.4x
---
As of 2022-12-04

Company Information

Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The Company’s lead product candidate is ANEB-001, a potent, small molecule cannabinoid receptor antagonist, to address the unmet medical need for a specific antidote for ACI. ANEB-001, is intended to rapidly reverse the negative effects of ACI within one hour of administration. The signs and symptoms of ACI range from profound sedation to anxiety and panic to psychosis with hallucinations. CB1 receptors are concentrated in the brain and central nervous system, while CB2 receptors are found mostly in peripheral organs and are associated with the immune system.

Contact Information

Headquarters
1415 Ranch Road 629 South, Suite 201LAKEWAY, TX, United States 78734
Phone
512-598-0931
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$67.9M
Revenue (TTM)
$0.00
Shares Outstanding
25.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.34
Book Value
$0.65
P/E Ratio
-7.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.